<DOC>
	<DOC>NCT01223924</DOC>
	<brief_summary>This is a randomized double-blinded placebo-controlled，single-dose escalation trial in healthy volunteer.</brief_summary>
	<brief_title>Single-dose Escalation Trial of M2ES in Healthy Volunteer</brief_title>
	<detailed_description>Randomized double-blinded placebo-controlled，single-dose escalation trial in health volunteer,to determine the safety and the max tolerate dose in health volunteer.</detailed_description>
	<criteria>1. Physical and mental healthy on the basis of a medical evaluation that reveals the absence of any clinically relevant abnormality and includes a physical examination, medical history, electrocardiogram (ECG), vital signs, and the results of blood biochemistry, blood coagulation and hematology tests and a urinalysis carried out at screening. 2. 19 to 45 years of age. 3. Body mass index (1925 kg/m2) ,the body weight ≥55kg for male subject,≥45kg for female. 4. Negative pregnant test, no menstrual period for female. 5. willing to comply with the protocol. 1. Be allergic to endostatin 2. Have taken any drug during the last 2 weeks 3. Have Participated any clinical trail during the last 2 week 4. Cardiovasculre, respiratory, Liver, renal, gastrointestinal hematologic endocrine and mental disease 5. HIV1 infected 6. HBV, HBV infected ,Hepatitis B surface antigen positive</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>cancer</keyword>
</DOC>